FDA Rejects Uterine Fibroid Drug

Written on .

The U.S. Food and Drug Administration has rejected a medication called Ulipristal Acetate, made by Allergan. The drug is already in use in Europe and post-market studies indicate a risk of serious liver disease. Read more: https://www.in-pharmatechnologist.com/Article/2018/08/23/Allergan-says-safety-concerns-prompted-US-FDA-rejection

Print